Director Zohar Shlomo of Delek US Holdings (NYSE:DK) executed a sale of 5,000 common shares on March 9, 2026, at a per-share price of $41.465, producing proceeds of approximately $207,325. The transaction, recorded in a Form 4 filing with the Securities and Exchange Commission, left Shlomo with a direct holding of 13,989 shares following the sale.
The disposition occurred as the company’s stock has delivered a substantial gain for holders over the prior 12 months, rising roughly 205% over that period. At the time of the disclosure the share price was trading at $41.88 and the company carried a market capitalization near $2.5 billion.
Alongside the insider transaction, Delek US released its fourth-quarter 2025 financial results. The company reported an adjusted earnings per share of $2.31, notably above the consensus forecast of -$0.07 - a variance the company’s reporting characterized as a significant positive surprise. By contrast, Delek US reported revenue of $2.43 billion for the quarter, short of the $2.55 billion that analysts had expected, representing a negative surprise on the top line.
These results paint a mixed picture: the adjusted EPS outcome highlights stronger-than-anticipated profitability metrics for the period, while the revenue figure indicates the company fell short of sales expectations. The filing and the quarterly results have prompted attention from market participants tracking both insider activity and quarterly performance metrics.
Market research referenced in the company’s regulatory disclosure notes that InvestingPro analysis views the stock as remaining undervalued versus its Fair Value. The same commentary points interested investors to a dedicated Pro Research Report available through InvestingPro for more detailed valuation and performance analysis of DK.
Investors and analysts are likely to maintain focus on subsequent company disclosures and operational updates to reconcile the divergence between earnings outperformance and revenue underperformance, and to incorporate insider trading disclosures into their ongoing assessments of Delek US’s financial trajectory.